NCT05263609 2022-08-02Optimizing Pembrolizumab Therapy With Timing and Intensification With AxitinibUniversity of OklahomaPhase 2 Withdrawn
NCT04197219 2020-11-05Pembrolizumab With Axitinib in Recurrent Endometrial CancerCase Comprehensive Cancer CenterPhase 2 Withdrawn
NCT03275558 2018-07-19Clinical Trial of the Use of the Nasal Spray of Patients With Recurrence of GlioblastomaCenter Trials & TreatmentPhase 1 Withdrawn